GlaxoSmithKline should be split, star investor Woodford says
-
8 January 2016
- From the section Business
The UK’s biggest drugs company should be split up, says one of Britain’s most successful and influential investors.
Neil Woodford said GlaxoSmithKline needs radical restructuring.
The founder of Woodford Investment Management …
Read the full article at: http://www.bbc.co.uk/news/business-35259184